Omega Fund VI, L.P. - 20 Jul 2021 Form 4 Insider Report for Imago BioSciences, Inc.

Reporting relationship: Former 10% owner
Issuer ticker: N/A
Reported as of: 20 Jul 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Jul 2021, 17:52:35 UTC
Prior SEC filing: 19 Jul 2021
Next SEC filing: 06 Oct 2021
Source filing: View source filing
Reporting owner signature: See Remarks

Key filing fact

Omega Fund VI, L.P. filed Form 4 for Imago BioSciences, Inc. on 20 Jul 2021.

Key facts

This page summarizes Omega Fund VI, L.P.'s Form 4 filing for Imago BioSciences, Inc..
4 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 20 Jul 2021, 17:52.

Change

Previous filing in this sequence was filed on 19 Jul 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMGO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +2,275,909
Change %: +910%
Price
Shares after: 2,525,909
Date: 20 Jul 2021
Ownership: Direct
Footnotes: F1, F2

IMGO transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +492,828
Change %: +20%
Price
Shares after: 3,018,737
Date: 20 Jul 2021
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMGO transaction Derivative

Series B convertible Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -2,275,909
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 20 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,275,909
Exercise price
Footnotes: F1, F2

IMGO transaction Derivative

Series C convertible Preferred Stock

Conversion of derivative security

Transaction value: $0
Shares: -492,828
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 20 Jul 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 492,828
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each share of the issuer's Series B Preferred Stock and Series C Preferred Stock automatically converted into one (1) shares of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on July 20, 2021 and had no expiration date.

Footnote F2

The reported securities are beneficially owned by Omega Fund VI, L.P. ("Omega VI"). The reported securities may be deemed to be beneficially owned by each of Omega Fund VI GP, L.P. ("Omega VI GP"), as the general partner of Omega VI, and Omega Fund VI GP Manager, Ltd. ("Omega VI GP Manager"), as the general partner of Omega VI GP. Otello Stampacchia, Claudio Nessi and Anne-Mari Paster are all the shareholders and directors of Omega VI GP Manager and have shared voting and investment power over the shares held by Omega VI and, as a result, may each be deemed to beneficially own the reported securities. Each of such individuals disclaims beneficial ownership of the shares held by Omega VI.

SEC remarks

Omega Fund VI, L.P., by Omega Fund VI GP, L.P., its general partner, by Omega Fund VI GP Manager, Ltd., its general partner /s/ Anne-Mari Paster /s/ Claudio Nessi /s/ Otello Stampacchia